Tap Native Launches Precision Bidding by NPI, Empowering Pharma Marketers to Reach HCPs at the Individual Level

RAMSEY, N.J., May 22, 2025 /PRNewswire/ — Tap Native, a leading healthcare-focused digital advertising platform, today announced the launch of its new Bid by NPI capability, a precision targeting feature that enables pharmaceutical advertisers to assign custom cost-per-click (CPC) bids to individual healthcare professionals (HCPs) using their National Provider Identifier (NPI).

This new feature represents a shift away from legacy decile-based targeting models, which broadly group providers by prescribing volume. With Bid by NPI, marketers can now strategically prioritize physicians and other HCPs based on specialty, historical engagement, therapeutic alignment, or other campaign-specific attributes—maximizing budget efficiency and ROI.

“By allowing marketers to bid by NPI, we’re giving them a tool to align their investments directly with their goals,” said RJ Lewis, Co-Founder of Tap Native. “Every healthcare professional has a unique value to each brand. Our platform now reflects that reality.”

Tap Native’s authenticated HCP reach already spans more than 82% of U.S.-based healthcare providers across a wide range of digital properties. With this new targeting precision, brands can reach their highest-priority audiences more effectively, with real-time control over how and where ad spend is allocated.

“This bidding feature gives advertisers more power to connect meaningfully with their most important audiences,” said Rafael Cosentino, Vice President of Business Development at Tap Native. “We’re excited to bring greater efficiency and accountability to the healthcare advertising landscape.”

The introduction of NPI-level bidding aligns with the industry’s broader transition toward data-driven strategies that emphasize measurable performance and person-level engagement. It also supports publishers by improving campaign effectiveness and engagement rates.

As healthcare marketers continue to seek greater transparency and value from their advertising investments, tools like Bid by NPI offer a future-ready approach to reaching the right providers at the right moment, with maximum relevance.

About Tap Native

Tap Native is a performance-driven digital advertising platform purpose-built for healthcare. The company connects health brands with authenticated healthcare professionals and engaged consumer audiences across high-quality publisher environments. Tap Native enables advanced targeting, contextual placements, and real-time optimization to deliver measurable outcomes for advertisers.

Media Contact:
Madison Crane
mcrane@ehsmail.com

View original content:https://www.prnewswire.com/news-releases/tap-native-launches-precision-bidding-by-npi-empowering-pharma-marketers-to-reach-hcps-at-the-individual-level-302463636.html

SOURCE Tap Native

Staff

Recent Posts

Private Wellness Club Continuum Unlocks Final Membership Tier at West Village Flagship

The New Year Introduces Continuum's Entry-Level Tier, Starting at $25,000 Per YearNEW YORK, Dec. 22,…

3 hours ago

Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach

BOSTON, Dec. 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with…

3 hours ago

KLAS Report Shows Strong Early Results for TrustCommerce Cloud Payments

CHICAGO, Dec. 22, 2025 /PRNewswire/ -- TrustCommerce®, a Sphere company and leading provider of end-to-end…

3 hours ago

BioFlorida Announces Appointment of Dr. Anthony Japour, CEO of iTolerance, Inc., as Chair of the Southeast Chapter

MIAMI, Dec. 22, 2025 /PRNewswire/ -- BioFlorida, Inc. ("BioFlorida"), Florida's preeminent life sciences association, is…

3 hours ago

Truemed Closes $34 Million Series A To Unlock HSA/FSA Funds For Lifestyle Interventions

Andreessen Horowitz leads the funding round which will accelerate the company's leadingtelehealth marketplaceAUSTIN, Texas, Dec.…

3 hours ago

Trump’s Marijuana Schedule III Order Launches a Federally Regulated Healthcare Sector

MMJ's position is further fortified by its FDA Orphan Drug Designations for the treatment of…

3 hours ago